24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
ADHD
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:16
Joonko founder Ilite Raz pleads guilty to a massive $27 million fraud
13:23
When product enthusiasm masquerades as market demand
09:21
The biggest blind spot in autonomous driving is the car itself
08:16
“We want to turn high performance into high reliability”: The engineer behind China’s fastest humanoid robot
More stories
Buzz
Most popular
Daily
Weekly
1
She sold her startup to Salesforce. Then she had four kids and started another one.
2
Meta loses its $1.5 billion AI recruit less than a year after hiring him
3
Secretive defense startup Covenant emerges from stealth with $250 million at over $1 billion valuation
4
The iPhone Duo is Apple’s answer to foldables. But what is the question?
5
“We proved there are no sacred cows in technology”: Island founder says the company can be worth tens of billions
More news
ADHD
4 stories about ADHD
“There are so few female founders; this has to be put in the past”
21.08.24
|
Ariela Karmel
Eve Mamane, Co-Founder and CRO of mental health startup Agave Health, spoke to CTech about founding her first venture, the need to normalize female founders, and why the tech industry must eliminate outdated limitations on women in leadership roles
Israeli app launches in the U.S. and Israel, helping parents of ADHD children
15.01.24
|
James Spiro
Pery uses clinical data and LLMs to provide advice and analysis for parents managing children diagnosed with attention deficit hyperactivity disorder
“There is a $5 billion opportunity in the ADHD market”
30.01.23
|
CTech
MindTension has raised a total of $2 million for its tool helping diagnose and treat optimization of ADHD and related mental health comorbidities
Teva Reaches Confidential Patent Settlement with Neos
27.12.18
|
CTech
The agreement will enable Teva to manufacture and sell a generic version of Neos’ ADHD drug Cotempla as of 2026